Transdermal Patch Market Report 2025 (Global Edition)

Global Transdermal Patch Market Report 2024 Market Size Split by Product Outlook: (Single-Layer Drug-In-Adhesive, Multi-Layer Drug-In-Adhesive, Matrix, Reservoir, Vapor, Others), by Type Outlook: (Fen...

Transdermal Patch Market Report Description

We have various report editions of Transdermal Patch Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Transdermal Patch Market Insights Video

Competitive Landscape of the Transdermal Patch Market

In the transdermal patch market's competitive landscape, numerous key competitors are driving innovation and growth. These developments reflect the industry's commitment to advancing transdermal drug delivery technologies.

In June 2024, 3M Company received FDA approval for its Duloxetine Topical Patch 50 mcg/hour, expanding its transdermal product offerings. (Source: https://www.prnewswire.com/news-releases/global-transdermal-skin-patches-market-forecast-report-2024-2030-a-9-9b-projected-industry-dominated-by-teva-pharma-3m-company-nitto-denko-corporation-and-johnson--johnson-302039341.html) In October 2024, Tonik began distributing transdermal vitamin and botanical patches across Asia, aiming to provide a convenient alternative for nutrient intake. (Source: https://www.nutraingredients-asia.com/Article/2024/10/30/tonik-launching-transdermal-vitamin-botanical-patches-across-asia/) In November 2024, Amneal Pharmaceuticals announced the launch of a generic version of the Butrans (buprenorphine) Transdermal System, providing a new option for pain management. (Source: https://investors.amneal.com/news/press-releases/press-release-details/2024/Amneal-Resubmits-DHE-Autoinjector-New-Drug-Application-and-Receives-U.S.-FDA-Approval-of-Exenatide-its-First-Generic-Injectable-GLP-1-Agonist/default.aspx)

Top Companies Market Share in Transdermal Patch Industry: (In no particular order of Rank)

• Johnson & Johnson (U.S.)
• Viatris Inc. (U.S.)
• Hisamatsu Pharmaceuticals Co. Ltd. (Japan)
• USB S.A. (Belgium)
• Boehringer Ingelheim International GmbH (Germany)
• Endo International plc. (Ireland)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Agile Therapeutics (U.S.)
• Bayer AG (Germany)
• Nitto Denko Corporation (Japan)
• Cipla Inc. (India)
• Iontopatch (U.S.)
• Medherant Limited (U.K.)
• AdhexPharma (France)
• Evernow (U.S.)
• Amneal Pharmaceuticals LLC. (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Alvogen Group Inc. (U.S.)
• Sparsha Pharma International Pvt Ltd (India)
• Luye Pharma Group (China)
• Novartis AG (Switzerland)
• AbbVie Inc. (U.S.)
• LEAD CHEMICAL Co. Ltd. (Japan)
• Purdue Pharma L.P (U.S.)
• Mundipharma International (U.K.).
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Transdermal Patch Market

Which Region Dominates the Transdermal Patch Market in 2024?

According to Cognitive Market Research, North America currently dominates the transdermal patch market, and the region is expected to have significant growth during the projected period. This is due to the high prevalence of chronic diseases such as diabetes, cardiovascular disorders, and chronic pain conditions. The region’s advanced healthcare infrastructure supports the adoption of innovative drug delivery systems, while regulatory bodies such as the FDA play a crucial role in ensuring product safety and efficacy.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). A growing population with chronic diseases, as well as a greater emphasis on improving healthcare accessibility. As urbanization and disposable incomes rise, more patients can afford modern treatment options such as transdermal medication delivery systems.

The current report Scope analyzes Transdermal Patch Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Transdermal Patch

According to Cognitive Market Research, the global transdermal patch market size was estimated at USD 6651.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 2660.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the transdermal patch market with a market size of USD 2099.21 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. The high prevalence of chronic diseases and a strong focus on innovative drug delivery systems drive market growth.
• The Canada transdermal patch market had a market share of USD 319.27 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. Supportive healthcare policies and the increasing adoption of advanced medical technologies bolster the market.
• The Mexico transdermal patch market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 242.11 million in 2024.

Europe Transdermal Patch

According to Cognitive Market Research, the global transdermal patch market size was estimated at USD 6651.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1995.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• The United Kingdom transdermal patch market had a market share of USD 335.24 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. In the U.K., transdermal patch sales witness an upswing due to a robust pharmaceutical sector and emphasis on patient compliance.
• The France transdermal patch market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD 183.58 million in 2024.
• According to Cognitive Market Research, the German transdermal patch market size was valued at USD 395.10 million in 2024 and is projected to grow at a CAGR of 3.9% during the forecast period. In Germany, transdermal patch surged due to advanced healthcare infrastructure and significant R&D investments.
• The Italy transdermal patch market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 171.61 million in 2024.
• The Russia transdermal patch market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 309.29 million in 2024.
• The Spain transdermal patch market is projected to witness growth at a CAGR of 2.8% during the forecast period with a market size of USD 163.63 million in 2024
• The Luxembourg transdermal patch market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 61.86 million in 2024.
• The Portugal transdermal patch market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 41.90 million in 2024.
• The Greece transdermal patch market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 23.95 million in 2024.
• The Rest of Europe's transdermal patch market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 309.29 million in 2024.

Asia Pacific Transdermal Patch

According to Cognitive Market Research, the global transdermal patch market size was estimated at USD 6651.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1529.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

• According to Cognitive Market Research, the China transdermal patch market size was valued at USD 688.43 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. Transdermal patches surged in China due to rapid urbanization and a growing middle class increased demand for convenient drug delivery methods.
• The Japan transdermal patch market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 211.12 million in 2024.
• The India transdermal patch market had a market share of USD 183.58 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period. Rising healthcare awareness and government initiatives improve access to transdermal therapies.
• The South Korean transdermal patch market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 152.98 million in 2024.
• The Australian transdermal patch market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 79.55 million in 2024.
• The South East Asia transdermal patch market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 105.56 million in 2024.
• The Rest of Asia Pacific transdermal patch market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 108.62 million in 2024.

South America Transdermal Patch

According to Cognitive Market Research, the global transdermal patch market size was estimated at USD 6651.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 332.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil transdermal patch market size was valued at USD 142.34 million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. Transdermal patches flourished in Brazil due to expanding healthcare services and a focus on non-invasive treatments.
• Argentina's transdermal patch market had a market share of USD 55.87 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Improving healthcare infrastructure and increased chronic disease prevalence boost demand for transdermal patches.
• Colombia transdermal patch market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 29.60 million in 2024.
• Peru transdermal patch market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 27.27 million in 2024.
• Chile transdermal patch market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 23.95 million in 2024.
• The Rest of Latin America's transdermal patch market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 53.54 million in 2024.

Middle East and Africa Transdermal Patch

According to Cognitive Market Research, the global transdermal patch market size was estimated at USD 6651.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 133.03 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031..

• The GCC Countries' transdermal patch market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 56.94 million in 2024. Transdermal patch sales flourish due to rising investments in healthcare and a focus on advanced medical solutions.
• The Egypt transdermal patch market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 13.97 million in 2024.
• The South Africa transdermal patch market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 21.02 million in 2024. Transdermal patch sales flourished in South Africa due to growing healthcare expenditure and efforts to enhance patient compliance.
• The Turkey transdermal patch market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 11.44 million in 2024.
• The Nigeria transdermal patch market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 13.97 million in 2024.
• The Rest of the MEA transdermal patch market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 15.70 million in 2024.

Transdermal Patch Market Analysis

How are Segments Performing in the Global Transdermal Patch Market?

transdermal patch market Product Segment Analysis

The matrix is the fastest-growing segment in the transdermal patch market. These patches combine the medicine with a polymer matrix that clings directly to the skin, allowing for constant drug diffusion. Their ease of use and little risk of leakage make them excellent for long-term treatments. Matrix patches are increasingly being used for nicotine replacement therapy and chronic disease treatment.

According to Cognitive Market Research, multi-layer drug-in-adhesive are likely to dominate the transdermal patch market over the forecast period. These patches have numerous layers of adhesive, each carrying a distinct active pharmaceutical ingredient (API), allowing for controlled and extended medication release. This technology is commonly used for chronic illnesses such as pain management and hormone therapy, which require long-term efficacy and steady plasma medication levels.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Transdermal Patch Industry. Request a Free Sample PDF!

Transdermal patch market Type Segment Analysis

In the transdermal patch market, the buprenorphine transdermal patch has been expanding at a rapid pace. Buprenorphine patches are used to treat chronic pain and opioid dependence, providing a non-invasive, sustained-release alternative to oral drugs.

According to Cognitive Market Research, the nicotine transdermal patch segment holds the largest share of the market. These patches are commonly used to aid in smoking cessation by administering controlled dosages of nicotine to ease withdrawal symptoms, making them a popular choice among those looking to quit smoking.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Transdermal Patch Application Outlook: Segment Analysis

Transdermal patch Market Application Segment Analysis

In the transdermal patch market, the rapidly growing sector is the smoking reduction and cessation aid category. This surge is driven by heightened awareness of the health risks related to smoking and the increasing adoption of smoking cessation programs.

According to Cognitive Market Research, the pain management/ relief segment holds the largest market share. This prominence is attributed to the high prevalence of chronic pain conditions, including arthritis, fibromyalgia, neuropathic pain, etc.

• Cardiovascular Disorder
• Central Nervous System Disorders (CNS)
• Pain Management/ Relief
• Smoking Reduction and Cessation Aid
• Overactive Bladder
• Nicotine Cessation
• Hormonal Therapy/ Disorders
• Dermatology
• Others

Transdermal Patch Technology Outlook: Segment Analysis

Transdermal patch Market Technology Segment Analysis

Mechanical arrays are projected to be the fastest-growing segment in the transdermal patch market. This technology employs microscopic needles to create transient microchannels in the skin, allowing for enhanced drug delivery without significant discomfort.

According to Cognitive Market Research, the chemical enhancers segment dominates the market. These agents facilitate drug permeation through the skin by temporarily altering its barrier properties, enabling the effective delivery of a wide range of medications.

• Electric Current
• Mechanical Arrays
• Thermal Ablation
• Chemical Enhancers
• Others

Transdermal Patch Distribution Channel Outlook: Segment Analysis

Transdermal Patch Market Distribution Channel Segment Analysis

Online pharmacies are projected to be the fastest-growing segment in the transdermal patch market. The convenience of home delivery, competitive pricing, as well as the increasing comfort of consumers with digital health services contribute to this rapid growth.

According to Cognitive Market Research, the hospital pharmacies segment dominates the market. This dominance is due to the direct access hospital pharmacies have to patients receiving immediate care, ensuring timely and controlled distribution of transdermal patches for various treatments.
 

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Transdermal Patch End User Outlook: Segment Analysis

Transdermal Patch Market End User Segment Analysis

Hospitals are projected to be the fastest-growing segment in the transdermal patch market. Hospitals represent a major portion of the market, particularly for patients requiring professional oversight for complex treatments.

According to Cognitive Market Research, the home care settings segment dominates the market. This dominance is driven by the growing preference for at-home medical treatments, offering patients the convenience of self-administration without frequent hospital visits.
 

• Home Care settings
• Hospitals
• Clinics

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion